Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983;106(3):159-70.
doi: 10.1007/BF00402602.

The experimental and clinical implications of cellular heterogeneity in malignant tumors

G Poste, R Greig

The experimental and clinical implications of cellular heterogeneity in malignant tumors

G Poste et al. J Cancer Res Clin Oncol. 1983.

Abstract

The growing body of evidence showing that malignant tumors are heterogeneous and contain diverse subpopulations of tumor cells is reviewed, with particular emphasis being given to the presence of tumor-cell subpopulations with differing metastatic properties. The factors that may influence the evolution of cellular diversity at different stages in the progression of malignant neoplasms are discussed. Emphasis is given to the possibility that interactions occurring amongst the constituent subpopulations of a malignant tumor may influence the rate at which new variant subpopulations emerge. Metastatic heterogeneity poses significant problems for experimental efforts to identify features unique to metastatic cells and also for the therapy of metastatic disease.

PubMed Disclaimer

References

    1. Cifone M, Fidler IJ (1981) Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci USA 78:6949–6952 - PMC - PubMed
    1. Fidler IJ (1973) Selection of successive tumor lines for metastasis Nature New Biol 242:148–149 - PubMed
    1. Fidler IJ, Kripke ML (1977) Metastasis results from pre-existing variant cells within a malignant tumor. Science 197:893–895 - PubMed
    1. Fidler IJ, Poste G (1982) The heterogeneity of metastatic properties in malignant tumor cells and regulation of the metastatic phenotype. In: Owens A (ed) Tumor cell heterogeneity. Academic Press, New York (in press)
    1. Fidler IJ, White RJ (1982) Design of models for testing cancer therapeutic agents. Van Nostrand, New York

Publication types

LinkOut - more resources